Trident Lifeline IPO will open for subscription from 26 September 2022. the company aims for an issue size of ₹35.34 Cr Cr through this IPO.
Trident Lifeline Limited
The company is engaged in the pharmaceutical business and ethical marketing in domestic as well as international markets. It is also engaged in the distribution of pharmaceutical products through third-party distribution networks. The company offers a wide range of pharmaceutical formulations and products manufactured on contract manufacturing under a loan license. It operates in India as well as African, Latin American and East Indian Countries. It has a presence through registered products or products under registration in countries like Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanmar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, and Venezuela.
Trident Lifeline deals in Capsules, Tablets, Liquid Ointment, Gel, Ice Gel, Mouthwash, Paste, Solution, Suspension, Drypowders, and Toothpaste. Its product portfolio comprises a wide range of drugs like Anti Bacterial, Anti Diarrheal, Anti Fungal, Anti Material, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protocol, Anti Histamine, Anti Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral Nyteraceutical, and Non-steroidal anti-inflammatory drug (NSAIDS). Its product portfolio consists of 832 products, as on 31 May 2022. As on 31 May 2022, it had 267 products registered in a total of 8 countries while 565 products were under the process of registration in 11 countries.
Trident Lifeline core business categories:
1. Ethical marketing of pharmaceutical formulation & products in the International Market through a third-party distribution network and sales force under its brand.
2. Getting the approved formulations manufactured through Contract Manufacturers, Source & Supply of Generic Pharma formulation and medicines in Domestic as well as International Market.
The company operates in India as well as African, Latin American and East Indian Countries. The company has a presence through registered products or products under registration in countries like Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanmar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, and Venezuela.
Basic details about the company
| Full name | Trident Lifeline Limited |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Company Website | http://www.tridentlifeline.com/ |
Objects of the Issue
- For Working Capital Requirements.
- To meet Public Issue Expenses.
- For Product registration in the international markets.
- General Corporate Purpose.
Dates to remember
| IPO Opening date | 26 September 2022 |
| IPO Closing | 29 September 2022 |
| Basis of Allotment | 04 October 2022 |
| Initiation Refunds | 06 October 2022 |
| Credit to Demat Account | 07 October 2022 |
| Listing Date | 10 October 2022 |
Trident Lifeline IPO Details
| Trident Lifeline IPO Date | Sep 26, 2022 to Sep 29, 2022 |
| Trident Lifeline IPO Face Value | ₹10 per share |
| Trident Lifeline IPO Price | ₹101 per share |
| Trident Lifeline IPO Lot Size | 1200 Shares |
| Issue Size | 3,499,200 shares of ₹10 (aggregating up to ₹35.34 Cr) |
| Fresh Issue | 3,499,200 shares of ₹10 (aggregating up to ₹35.34 Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | BSE SME |
Trident Lifeline IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1200 | ₹121,200 |
| Retail (Max) | 1 | 1200 | ₹121,200 |
Trident Lifeline IPO Reservation Details
| NII (HNI) Shares Offered | 50% |
| Retail Shares Offered | 50% |
Trident Lifeline Financial Performance
| FY2020 | FY2021 | FY2022 | |
| Revenue | 493.49 | 962.23 | 2,176.79 |
| Expenses | 608.23 | 892.74 | 1,931.10 |
| Net income | (79.63) | 63.23 | 227.32 |
Trident Lifeline Valuations & Margins
| FY 2020 | FY 2021 | FY 2022 | |
| EPS | (3.12) | 1.53 | 3.98 |
| PE ratio | – | – | 25.38 |
| RONW (%) | – | – | 46.79 |
| NAV | – | – | 6.07 |
Company Promoters
- Mr. Hardik Jigishkumar Desai
- Mr. Mayurkumar Mansukhbhai Gajera
- Mrs. Rupaben C Jariwala
- Mrs. Rinkal Mayurbhai Gajera
- Mr. Tarang Nathabhai Gajera
- Mr. Mohak Nathabhai Gajera
Trident Lifeline IPO Promoter Holding
| Pre Issue Share Holding | 100% |
| Post Issue Share Holding | – |
Lead Manager(s)
- Beeline Capital Advisors Pvt Ltd
Trident Lifeline Offer Registrar
LINK INTIME INDIA PRIVATE LIMITED
C-101, 1st Floor, 247 Park
L.B.S. Marg, Vikhroli West
Mumbai – 400 083, Maharashtra
Phone: +91 22 4918 6200
Email: trilife.ipo@linkintime.co.in
Website: www.linkintime.co.in
Trident Lifeline Contact Details
TRIDENT LIFELINE LIMITED
2001, 2nd Floor, APMC, Krushi
Bazar, Begumpura, Falsawadi,
Ring Road, Surat – 395003, Gujarat
Phone: +91 0261 – 2490224
Email: compliance@tridentlifeline.com
Website: www.tridentlifeline.com
Trident Lifeline IPO Allotment Status
Trident Lifeline IPO allotment will be available on Link Intime’s website. Click on this link to get allotment status.
Final thoughts
Trident Lifeline IPO is going to hit Dalal street soon. applying for IPO is purely a personal choice. study well about the company and do subscribe if you are feeling good about the company. I hope this post will give you enough details to make a fundamental study of the company. learn well and make wise decisions.
Happy Investing
